REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 12 filers reported holding REGENERON PHARMACEUTICALS in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gladius Capital Management LP | 30,000 | $21,556,200 | 1.05% |
| HRT FINANCIAL LP | 11,300 | $8,119 | 0.08% |
| Maven Securities LTD | 3,700 | $2,659,317 | 0.04% |
| SIMPLEX TRADING, LLC | 62,200 | $44,693 | 0.04% |
| IMC-Chicago, LLC | 49,700 | $35,711,438 | 0.03% |
| Allianz Asset Management GmbH | 24,900 | $17,891,646 | 0.03% |
| JANE STREET GROUP, LLC | 85,300 | $61,291,462 | 0.02% |
| GROUP ONE TRADING, L.P. | 3,300 | $2,371,182 | 0.01% |
| Twin Tree Management, LP | 4,300 | $3,089,722 | 0.01% |
| SG Americas Securities, LLC | 20,100 | $624 | 0.01% |
| JPMORGAN CHASE & CO | 67,100 | $48,214,034 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
This page lists REGENERON PHARMACEUTICALS's shareholders in Q2 2023. To view REGENERON PHARMACEUTICALS's shareholder history, click here.